SCHEMBL4571000

SCHEMBL4571000

CNS(=O)(=O)c1cccc(C(CCC(CCc2ccccc2)C(=O)O)COC(C)=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
F10 P00742 2/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
AGTR1 P30556 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 1/20 0.36
AKR1C3 P42330 1/20 0.36
NQO2 P16083 1/20 0.35
MTNR1A P48039 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4443579 0.85 POLB (0.53) POLBTDP1ALDH1A1CYP1A2CYP2C9
SCHEMBL1856429 0.77 POLB (0.51) POLBTDP1ALDH1A1CYP1A2CYP2C9
SCHEMBL1857400 0.74 POLB (0.49) POLBTDP1ALDH1A1CYP1A2CYP2C9
SCHEMBL1859707 0.72 POLB (0.53) POLBTDP1ALDH1A1CYP1A2CYP2C9
SCHEMBL1856417 0.71 MMP2 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL1857442 0.70 CPA3 (0.49) ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL20642242 0.68 ALDH1A1 (0.46) TDP1MEN1KMT2AALDH1A1LMNA
SCHEMBL31689561 0.67 SLC7A5 (0.59) TDP1KDM4E
SCHEMBL20032309 0.66 TNNI3K (0.45) TDP1KMT2ASMN1; SMN2L3MBTL1LMNA
SCHEMBL8039484 0.66 HTR6 (0.58) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed